WNT3 and membrane-associated β-catenin regulate trophectoderm lineage differentiation in human blastocysts

Molecular Human Reproduction

Volumn 21, Issue 9, 2015, Pages 711-722

  Krivega, M ^a   Essahib, W ^a   Van de Velde, H ^a,b  

^a FACULTY OF MEDICINE AND PHARMACY   (Belgium)

^b CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

EOMES; Human embryo; Trophoblast; WNT; catenin

Indexed keywords

1 AZAKENPAULLONE; BETA CATENIN; CARDAMONIN; CHEMICAL COMPOUND; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; LEVO AZAKENPAULLONE; OCTAMER TRANSCRIPTION FACTOR 4; RNA; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; WNT3 PROTEIN; CTNNB1 PROTEIN, HUMAN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MESSENGER RNA; PROTEIN KINASE INHIBITOR; WNT3 PROTEIN, HUMAN;

ARTICLE; BLASTOCYST; BRAIN CORTEX; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO CULTURE; EMBRYO DEVELOPMENT; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFERTILITY THERAPY; INNER CELL MASS; LOSS OF FUNCTION MUTATION; MEMBRANE; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; STEM CELL; TROPHECTODERM; TROPHOBLAST; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; EMBRYONIC STEM CELL; GENE EXPRESSION REGULATION; HELA CELL LINE; METABOLISM; TIME FACTOR; WNT SIGNALING PATHWAY;

BETA CATENIN; BLASTOCYST; CELL DIFFERENTIATION; CELL LINEAGE; EMBRYO CULTURE TECHNIQUES; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLYCOGEN SYNTHASE KINASE 3; HELA CELLS; HUMANS; PROTEIN KINASE INHIBITORS; RNA, MESSENGER; TIME FACTORS; TROPHOBLASTS; WNT SIGNALING PATHWAY; WNT3 PROTEIN;

EID: 84940878951     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gav036     Document Type: Article

References (92)

1. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997;16:3797-3804.
2. Abu-Remaileh M, Gerson A, Farago M, Nathan G, Alkalay I, Zins Rousso S, Gur M, Fainsod A, Bergman Y. Oct-3/4 regulates stem cell identity and cell fate decisions by modulating Wnt/b-catenin signalling. EMBO J 2010; 29:3236-3248.
3. Adjaye J, Huntriss J, Herwig R, BenKahla A, Brink TC,Wierling C, Hultschig C, Groth D, Yaspo ML, Picton HM et al. Primary differentiation in the human blastocyst: comparative molecular portraits of inner cell mass and trophectoderm cells. Stem Cells 2005;23:1514-1525.
4. Amin N, Vincan E. The Wnt signaling pathways and cell adhesion. Front Biosci (Landmark Ed) 2012;17:784-804.
5. Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA, Itskovitz-Eldor J, Thomson JA. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 2000;227:271-278.
6. Archbold HC, Yang YX, Chen L, Cadigan KM. Howdo they doWntthey do?: regulation of transcription by the Wnt/b-catenin pathway. Acta Physiol (Oxf) 2012;204:74-109.
7. Arkell RM, Fossat N, Tam PP. Wnt signalling in mouse gastrulation and anterior development: new players in the pathway and signal output. Curr Opin Genet Dev 2013;23:454-460.
8. Barrow JR, Howell WD, Rule M, Hayashi S, Thomas KR, Capecchi MR, McMahon AP. Wnt3 signaling in the epiblast is required for proper orientation of the anteroposterior axis. Dev Biol 2007;312:312-320.
9. Beurel E, Grieco SF, Jope RS. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther 2015;148C:114-131.
10. Blauwkamp TA, Nigam S, Ardehali R, Weissman IL, Nusse R. Endogenous Wnt signalling in human embryonic stem cells generates an equilibrium of distinct lineage-specified progenitors. Nat Commun 2012;3:1070.
11. Bone HK, Nelson AS, Goldring CE, Tosh D,Welham MJ. A novel chemically directed route for the generation of definitive endoderm from human embryonic stem cells based on inhibition of GSK-3. J Cell Sci 2011; 124:1992-2000.
12. Buxton RS, Magee AI. Structure and interactions of desmosomal and other cadherins. Semin Cell Biol 1992;3:157-167.
13. Cauffman G, Van de Velde H, Liebaers I, Van Steirteghem A. DAZL expression in human oocytes, preimplantation embryos and embryonic stem cells. Mol Hum Reprod 2005;11:405-411.
14. Cauffman G, Liebaers I, Van Steirteghem A, Van de Velde H. POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 2006;24:2685-2691.
15. Cauffman G,DeRyckeM, SermonK, Liebaers I, VandeVelde H. Markersthat define stemness in ESC are unable to identify the totipotent cells in human preimplantation embryos. Hum Reprod 2009;24:63-70.
16. Chen AE, Egli D, Niakan K, Deng J, Akutsu H, Yamaki M, Cowan C, Fitz-Gerald C, Zhang K, Melton DA et al. Optimal timing of inner cell mass isolation increases the efficiency of human embryonic stem cell derivation and allows generation of sibling cell lines. Cell Stem Cell 2009; 4:103-106.
17. ChenY,Wang K, Gong YG, Khoo SK, Leach R. Roles ofCDX2and EOMESin human induced trophoblast progenitor cells. Biochem Biophys Res Commun 2013;431:197-202.
18. Cho M, Ryu M, Jeong Y, Chung YH, Kim DE, Cho HS, Kang S, Han JS, Chang MY, Lee CK et al. Cardamonin suppresses melanogenesis by inhibition of Wnt/beta-catenin signaling. Biochem Biophys Res Commun 2009;390:500-505.
19. Clevers H, Nusse R. Wnt/b-catenin signaling and disease. Cell 2012; 149:1192-1205.
20. D'Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005;23:1534-1541.
21. Davidson KC, Adams AM, Goodson JM, McDonald CE, Potter JC, Berndt JD, Biechele TL, Taylor RJ, Moon RT. Wnt/b-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4. Proc Natl Acad Sci U S A 2012;109:4485-4490.
22. De Paepe C, KrivegaM, Cauffman G, Geens M, Van de Velde H. Totipotency and lineage segregation in the human embryo. Mol Hum Reprod 2014; 20:599-618.
23. Devroey P,Van Steirteghem A. Areview of ten years experience of ICSI.Hum Reprod Update 2004;10:19-28.
24. Dobson AT, Raja R, Abeyta MJ, Taylor T, Shen S, Haqq C, Pera RA. The unique transcriptome through day 3 of human preimplantation development. Hum Mol Genet 2004;13:1461-1470.
25. Dravid G, Ye Z, Hammond H, Chen G, Pyle A, Donovan P, Yu X, Cheng L. Defining the role of Wnt/beta-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells 2005;23:1489-1501.
26. Embryology ASiRMaESIGo. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 2011; 26:1270-1283.
27. Filali M, Cheng N, Abbott D, Leontiev V, Engelhardt JF. Wnt-3A/β-catenin signaling induces transcription from the LEF-1 promoter. J Biol Chem 2002;277:33398-33410.
28. Fu J, Jiang M, Mirando AJ, Yu HM, HsuW. Reciprocal regulation of Wnt and Gpr177/mouse Wntless is required for embryonic axis formation. Proc Natl Acad Sci U S A 2009;106:18598-18603.
29. Fukunaga Y, Liu H, Shimizu M, Komiya S, Kawasuji M, Nagafuchi A. Defining the roles of beta-catenin and plakoglobin in cell-cell adhesion: isolation of beta-catenin/plakoglobin-deficient F9 cells. Cell Struct Funct 2005; 30:25-34.
30. Goossens V, De Rycke M, De Vos A, Staessen C, Michiels A, VerpoestW, Van Steirteghem A, Bertrand C, Liebaers I, Devroey P et al. Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum Reprod 2008;23:481-492.
31. Greber B, Lehrach H, Adjaye J. Control of early fate decisions in human ES cells by distinct states of TGFbeta pathway activity. Stem Cells Dev 2008; 17:1065-1077.
32. Grumolato L, Liu G, Mong P, Mudbhary R, Biswas R, Arroyave R, Vijayakumar S, Economides AN, Aaronson SA. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev 2010;24:2517-2530.
33. Haegel H, Larue L, Ohsugi M, Fedorov L, Herrenknecht K, Kemler R. Lack of beta-catenin affects mouse development at gastrulation. Development 1995;121:3529-3537.
34. Hao J, Li TG, Qi X, Zhao DF, Zhao GQ. WNT/beta-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Dev Biol 2006;290:81-91.
35. He S, Pant D, Schiffmacher A, Meece A, Keefer CL. Lymphoid enhancer factor 1-mediated Wnt signaling promotes the initiation of trophoblast lineage differentiation in mouse embryonic stem cells. Stem Cells 2008; 26:842-849.
36. He K, Zhao H, Wang Q, Pan Y. A comparative genome analysis of gene expression reveals different regulatory mechanisms between mouse and human embryo pre-implantation development. Reprod Biol Endocrinol 2010;8:41.
37. Herr P, Hausmann G, Basler K. WNT secretion and signalling in human disease. Trends Mol Med 2012;18:483-493.
38. Hovanes K, LiTW, Munguia JE, Truong T, Milovanovic T, Lawrence Marsh J, Holcombe RF, Waterman ML. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 2001;28:53-57.
39. Huelsken J, Vogel R, Brinkmann V, Erdmann B, Birchmeier C, BirchmeierW. Requirement for beta-catenin in anterior-posterior axis formation in mice. J Cell Biol 2000;148:567-578.
40. James D, Levine AJ, Besser D, Hemmati-Brivanlou A. TGFbeta/activin/ nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 2005;132:1273-1282.
41. Jia D, YangW, Li L, Liu H, Tan Y, Ooi S, Chi L, Filion LG, Figeys D,Wang L. b-Catenin and NF-kB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer. Cell Death Differ 2014;22:298-310.
42. Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 1993;9:317-321.
43. Kim H,WuJ, Ye S, Tai CI, Zhou X, Yan H, Li P, PeraM, Ying QL. Modulation of b-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal. Nat Commun 2013;4:2403.
44. Kimura N, Nakashima K, Ueno M, Kiyama H, Taga T. A novel mammalian T-box-containing gene, Tbr2, expressed in mouse developing brain. Brain Res Dev Brain Res 1999;115:183-193.
45. Kolibianakis EM, Zikopoulos K, Smitz J, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists. Hum Reprod 2004;19:1525-1529.
46. Krivega MV, Geens M, Van de Velde H. CAR expression in human embryos and hESC illustrates its role in pluripotency and tight junctions. Reproduction 2014;148:531-544.
47. Kuijk EW, van Tol LT, Van de Velde H, Wubbolts R,Welling M, Geijsen N, Roelen BA. The roles of FGF and MAP kinase signaling in the segregation of the epiblast and hypoblast cell lineages in bovine and human embryos. Development 2012;139:871-882.
48. Lu J, Hou R, Booth CJ, Yang SH, Snyder M. Defined culture conditions of human embryonic stem cells. Proc Natl Acad Sci U S A 2006; 103:5688-5693.
49. Lyashenko N, Winter M, Migliorini D, Biechele T, Moon RT, Hartmann C. Differential requirement for the dual functions of b-catenin in embryonic stem cell self-renewal and germ layer formation. Nat Cell Biol 2011; 13:753-761.
50. Marchand M, Horcajadas JA, Esteban FJ, McElroy SL, Fisher SJ, Giudice LC. Transcriptomic signature of trophoblast differentiation in a human embryonic stem cell model. Biol Reprod 2011;84:1258-1271.
51. Meyers JR, Hu L, Moses A, Kaboli K, Papandrea A, Raymond PA. b-Catenin/ Wnt signaling controls progenitor fate in the developing and regenerating zebrafish retina. Neural Dev 2012;7:30.
52. Niakan KK, Eggan K. Analysis of human embryos from zygote to blastocyst reveals distinct gene expression patterns relative to the mouse. Dev Biol 2013;375:54-64.
53. O'Leary T, Heindryckx B, Lierman S, van Bruggen D, Goeman JJ, Vandewoestyne M, Deforce D, de Sousa Lopes SM, De Sutter P . Tracking the progression of the human inner cell mass during embryonic stem cell derivation. Nat Biotechnol 2012;30:278-282.
54. Parks JC, McCallie BR, Janesch AM, Schoolcraft WB, Katz-Jaffe MG. Blastocyst gene expression correlates with implantation potential. Fertil Steril 2011;95:1367-1372.
55. Pereira L, Yi F, Merrill BJ. Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal. Mol Cell Biol 2006; 26:7479-7491.
56. Platteau P, Laurent E, Albano C, Osmanagaoglu K, Vernaeve V, Tournaye H, Camus M, Van Steirteghem A, Devroey P. An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ ICSI. Hum Reprod 2003;18:1200-1204.
57. QiuW, Chen L, Kassem M. Activation of non-canonical Wnt/JNK pathway by Wnt3a is associated with differentiation fate determination of human bone marrow stromal (mesenchymal) stem cells. Biochem Biophys Res Commun 2011;413:98-104.
58. Reubinoff BE, PeraMF, FongCY,Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000;18:399-404.
59. Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R, Logtenberg T, Clevers H. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 1999;285:1923-1926.
60. Samarzija I, Sini P, Schlange T, Macdonald G, Hynes NE. Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways. Biochem Biophys Res Commun 2009; 386:449-454.
61. Sasaki H. Mechanisms of trophectoderm fate specification in preimplantation mouse development. Dev Growth Differ 2010;52:263-273.
62. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 2004;10:55-63.
63. Sikes JM, Bely AE. Making heads from tails: development of a reversed anterior-posterior axis during budding in an acoel. Dev Biol 2010; 338:86-97.
64. SinghAM,Reynolds D, CliffT, Ohtsuka S, Mattheyses AL, SunY, Menendez L, Kulik M, Dalton S. Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell 2012;10:312-326.
65. Sokol SY. Maintaining embryonic stem cell pluripotency with Wnt signaling. Development 2011;138:4341-4350.
66. Sui L, Mfopou JK, Geens M, Sermon K, Bouwens L. FGF signaling via MAPK is required early and improves Activin A-induced definitive endoderm formation from human embryonic stem cells. Biochem Biophys Res Commun 2012;426:380-385.
67. Sumi T, Tsuneyoshi N, Nakatsuji N, Suemori H. Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling. Development 2008;135:2969-2979.
68. Suwinska A, Ciemerych MA. Factors regulating pluripotency and differentiation in early mammalian embryos and embryo-derived stem cells. Vitam Horm 2011;87:1-37.
69. Tanaka SS, Kojima Y, Yamaguchi YL, Nishinakamura R, Tam PP. Impact of WNT signaling on tissue lineage differentiation in the early mouse embryo. Dev Growth Differ 2011;53:843-856.
70. ten Berge D, KooleW, Fuerer C, Fish M, Eroglu E, Nusse R. Wnt signaling mediates self-organization and axis formation in embryoid bodies. Cell Stem Cell 2008;3:508-518.
71. Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, Gardner RL, McKay RD. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007; 448:196-199.
72. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
73. Tian X, Liu Z, Niu B, Zhang J, Tan TK, Lee SR, Zhao Y, Harris DC, Zheng G. E-cadherin/b-catenin complex and the epithelial barrier. J Biomed Biotechnol 2011;2011:567305.
74. Ullmann U, In't Veld P, Gilles C, Sermon K, De Rycke M, Van de Velde H, Van Steirteghem A, Liebaers I. Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions. Mol Hum Reprod 2007;13:21-32.
75. UmeharaH,KimuraT,Ohtsuka S,NakamuraT,KitajimaK, IkawaM,OkabeM, Niwa H,Nakano T. Efficient derivation of embryonic stemcells by inhibition of glycogen synthase kinase-3. Stem Cells 2007;25:2705-2711.
76. VanCamp JK, Beckers S, Zegers D, Van HulW. Wntsignaling and the control of human stem cell fate. Stem Cell Rev 2014;10:207-229.
77. Van de Velde H, Nagy ZP, Joris H, De Vos A, Van Steirteghem AC. Effects of different hyaluronidase concentrations and mechanical procedures for cumulus cell removal on the outcome of intracytoplasmic sperm injection. Hum Reprod 1997;12:2246-2250.
78. Van der Jeught M, O'Leary T, Ghimire S, Lierman S, Duggal G, Versieren K, Deforce D, Chuva de Sousa Lopes S, Heindryckx B, De Sutter P. The combination of inhibitors of FGF/MEK/Erk and GSK3b signaling increases the number of OCT3/4- and NANOG-positive cells in the human inner cell mass, but does not improve stem cell derivation. Stem Cells Dev 2013;22:296-306.
79. Van Haute L, De Block G, Liebaers I, Sermon K, De Rycke M. Generation of lung epithelial-like tissue from human embryonic stem cells. Respir Res 2009;10:105.
80. Van Landuyt L, Van de Velde H, De Vos A, Haentjens P, Blockeel C, Tournaye H, Verheyen G. Influence of cell loss after vitrification or slow-freezing on further in vitro development and implantation of human Day 3 embryos. Hum Reprod 2013;28:2943-2949.
81. WangQT, Piotrowska K, Ciemerych MA, Milenkovic L, ScottMP, Davis RW, Zernicka-Goetz M. A genome-wide study of gene activity reveals developmental signaling pathways in the preimplantation mouse embryo. Dev Cell 2004;6:133-144.
82. Wray J, Hartmann C. WNTing embryonic stem cells. Trends Cell Biol 2012; 22:159-168.
83. Wray J, Kalkan T, Gomez-Lopez S, Eckardt D, Cook A, Kemler R, Smith A. Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat Cell Biol 2011;13:838-845.
84. Xiao L, Yuan X, Sharkis SJ. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 2006;24:1476-1486.
85. Xie H, Tranguch S, Jia X, Zhang H, Das SK, Dey SK, Kuo CJ, Wang H. Inactivation of nuclear Wnt-beta-catenin signaling limits blastocyst competency for implantation. Development 2008;135:717-727.
86. Xu RH, Chen X, Li DS, Li R, Addicks GC, Glennon C, Zwaka TP, Thomson JA. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 2002;20:1261-1264.
87. Xu RH, Sampsell-Barron TL, Gu F, Root S, Peck RM, Pan G, Yu J, Antosiewicz-Bourget J, Tian S, Stewart R et al. NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 2008;3:196-206.
88. Yadav VR, Prasad S, Aggarwal BB. Cardamonin sensitizes tumour cells to TRAIL through ROS- and CHOP-mediated up-regulation of death receptors and down-regulation of survival proteins. Br J Pharmacol 2012; 165:741-753.
89. Yan L, Yang M, Guo H, Yang L, Wu J, Li R, Liu P, Lian Y, Zheng X, Yan J et al. Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells. Nat Struct Mol Biol 2013;20:1131-1139.
90. Ying QL,Wray J, Nichols J, Batlle-Morera L, Doble B,Woodgett J, Cohen P, Smith A. The ground state of embryonic stem cell self-renewal. Nature 2008;453:519-523.
91. Zhang P, Zucchelli M, Bruce S, Hambiliki F, Stavreus-Evers A, Levkov L, Skottman H, Kerkelä E, Kere J, Hovatta O. Transcriptome profiling of human pre-implantation development. PLoS One 2009;4:e7844.
92. Zhou J, Qu J, Yi XP, Graber K, Huber L, Wang X, Gerdes AM, Li F. Upregulation of gamma-catenin compensates for the loss of beta-catenin in adult cardiomyocytes. Am J Physiol Heart Circ Physiol 2007;292:H270-H276.